Behavior, SexNCT03660709
Comparing the Efficacy of Enhanced and Standard HTC
A study testing Intervention in people with Behavior, Sex, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Objective The objectives of the study are to evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, increasing retesting rate and risk perception among men who have sex with men (MSM) in… Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Behavior, Sex
- What is being tested?
- Intervention
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 430 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Sep 2018to 30 Sep 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- men of age 18 years or above taking up HIV testing and counselling (HTC) at a collaborative non-governmental organization (NGO),
- anal intercourse with at least one man in the last six months
- able to read and comprehend Cantonese
- willingness to provide contact information and to complete a simple follow up evaluation at Month 6
- no intention to leave Hong Kong for one month consecutively within the next six months.
Who cannot join
- self-reported or tested to be HIV positive
Trial locations and contacts
1 site in 1 country.
Hong Kong1 site
Centre for Health Behaviours Research, the Chinese University of Hong Kong
Hong Kong, 666888
About this study
Official title: A RCT Evaluating the Efficacy of Enhanced and Standard Versions of HIV Testing and Counselling Among Men Who Have Sex With Men in Hong Kong
Objective The objectives of the study are to evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, increasing retesting rate and risk perception among men who have sex with men (MSM) in Hong Kong.
Participants Inclusion criteria are: 1) men of age 18 years or above using HTC services at AIDS Concern, 2) anal intercourse with at least one man in the last six months, 3) able to read and comprehend Cantonese, 4) willingness to provide contact information and to complete a simple follow up evaluation at Month 6, and 5) no intention to leave Hong Kong for one month consecutively within the next six months. Those self-reported or tested to be HIV positive will be excluded from the study.
Read more
Design A parallel-group and non-blinded randomized controlled trial (RCT) will be conducted. A total of 430 participants will be randomly allocated into the intervention group receiving EHTC (n=215) and the control group receiving SHTC (n=215). Evaluation will be performed six months afterwards.
Outcomes Primary outcomes are: 1) Prevalence of unprotected anal intercourse with any and specific types of male partners during the 6-month follow up period; 2) uptake of any type of HIV antibody testing within the 6-month follow-up period, and 3) HIV risk perception.
Read the detailed description
Aim To evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) that combines a component proven effective and new components involving e-health and HIV risk self-assessment versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, and increasing HIV retesting rate and risk perception among men who have sex with men (MSM) in Hong Kong.
Objectives To compare outcomes obtained from the intervention group (EHTC) and the control group (SHTC) at Month 6, including: 1) prevalence of unprotected anal intercourse with any type and specific types of male sex partners (regular and non-regular partners) in the last six months, 2) prevalence of having taken up any type of HIV antibody testing within the 6-month follow-up period, and 3) level of HIV risk perception.
Study design A parallel-group and non-blinded randomized controlled trial (RCT) will be conducted. A total of 430 participants will be randomly allocated into the intervention group receiving EHTC (n=215) and the control group receiving standard-of-care HTC (SHTC; n=215). Evaluation will be performed six month afterwards.
Recruitment procedures Users of AIDS Concern's HTC service will be approached by staff of AIDS Concern. They will brief the participants about the detail of the study and invite them to participate. Prospective participants who are interested in joining the study will be screened for their eligibility. Guarantees will be made on anonymity, right to quit at any time and that refusal will not affect their chance in using any services. Verbal instead of written informed consent will be obtained due to maintaining anonymity but the fieldworkers will sign a form pledging that the participants have been fully informed about the study.
Baseline survey and randomization Participants will complete a self-administered baseline questionnaire on site. Participants are randomized 1:1 into the intervention group and the control group. Staff of the NGO will draw one of the sealed opaque envelops to randomly allocate participants into the intervention and the control groups. Random numbers will be generated by a computer. Block randomization with block size of eight will be used.
Pre-test counselling and rapid testing All consented participants in both groups will receive the same standard-of-care pre-testing counselling, which has currently been provided by the NGO staff. It takes about five minutes to complete; it covers knowledge on HIV prevention, risk assessment, and explanation of the procedure and benefits of HTC. A rapid HIV antibody test (finger prick) will then be performed. Testing results will be known in about 15 minutes.
The control group Participants that are allocated to the control group will receive the standard-of-care HTC, which includes the previous pre-testing counselling procedures. In the post-testing counselling, participants will be explained about the negative HIV testing result (e.g. window period for screening). They will also be reminded about risk of HIV transmission, and be facilitated to set up specific goals for consistent condom use. The standard-of-care post-testing counselling lasts for about 15 minutes.
The intervention group In addition to the steps received by members of the control group, the intervention group will be exposed to four additional intervention components.
- A video clip While waiting for the HIV testing result, participants in the intervention group will watch a 10-minute video clip presenting the story of a gay man contracting sexually transmitted diseases in Hong Kong on a tablet.
- A pamphlet and post-test counselling promoting HIV retesting During the standard post-test counselling, the NGO staff will perform additional brief discussions about the importance of HIV retesting. A pamphlet promoting HIV retesting in the future six months will be prepared by this study and be distributed to participants after they have completed viewing the video.
- The e-health HIV risk calculator Through e-mail, SMS or social media means, participants will be suggested 3 and 5 months after receiving the EHTC to make a self-assessment of one's own HIV-related risk through an online personalized HIV risk self-assessment.
- Brief e-health reminder for retesting Brief SMS or social media messages will be sent to participants at Month 3 and 5.
Follow up evaluation Participants of both the intervention and control groups will be followed up six months after receiving the HTC.
Statistical analysis Intention-to-treat analysis will be conducted. Between-group (intervention versus control) baseline differences in the frequency distributions of potential confounders will be compared by using chi-square test, t-test, Mann-Whitney test or other statistics. The absolute and relative risks and number needed to treat (and their 95% confidence intervals) for the binary primary outcomes comparing the two groups at Months 6 will be derived. Adjusted comparisons between the intervention and control groups will be made for all binary outcomes, adjusting for any potential confounders showing p<.2 in the between-group baseline comparisons (if any), using modified Poisson regression with robust sandwich variance estimation. SPSS 18.0 will be used for data analysis; p<.05 (2-sided) will be taken as statistically significant. The research team is very experienced in performing data analysis.
Sample size planning Assuming the prevalence of UAI with any male partners in the last six months is 40% in the control group when measured at Month 6, a sample size of 152 per group allows us to detect a smallest between-group difference of UAI of 15% (power=0.8, alpha=0.05), taking into an expected 30% loss of follow up at Month 6. A target sample size of about 215 per group is required. The actual sample size will be 430 (215 for the intervention group and 215 for the control group).
- Conditions
- Behavior, Sex
- Being tested
- Intervention, Control
- Keywords
- Unprotected anal intercourse, HIV retesting, Risk perception
- Medical subject headings
- Sexual Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
InterventionBehavioural
- Standard-of-care HIV testing and counseling
- Watch a video clip while waiting for the HIV testing result on a tablet.
- Receive a pamphlet and post-test counselling promoting HIV retesting.
- Receive the e-health HIV risk calculator through e-mail, SMS or social media means 3 and 5 months afterwards.
- Receive brief e-health reminder for retesting at Month 3 and 5.
ControlBehavioural
Standard-of-care HIV testing and counseling
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | enhanced version of HIV testing and counseling Receives: Behavioral: Intervention |
| Control | Active comparator | standard-of-care HIV testing and counseling Receives: Behavioral: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Take up any type of HIV antibody testing
Uptake of any type of HIV antibody testing within the follow-up period will be assessed at Month 6 telephone follow-up evaluation
Measured: six months
Secondary outcomes (2)
Unprotected anal intercourse with any and specific types of male partners
Prevalence of unprotected anal intercourse with any and specific types of male partners will be recorded at Month 6 telephone follow-up evaluation
Measured: six months
Risk perception
Perceived risk of HIV infection will be assessed at Month 6 telephone follow-up evaluation
Measured: six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Sep 2018
- Study start1 Sep 2018
- Primary completion30 Sep 2019
- Study completion30 Sep 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Behavior, SexStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 430 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zixin Wang, Chinese University of Hong Kong
- Investigators
- Zixin Wang, PhD, Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03660709
- Sponsor's protocol ID
- MSS249R
- Status last verified
- May 2020
- First submitted
- 4 Sep 2018
- Last updated
- 21 May 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A RCT Evaluating the Efficacy of Enhanced and Standard Versions of HIV Testing and Counselling Among Men Who Have Sex With Men in Hong Kong
- ClinicalTrials.gov ID
- NCT03660709
- Acronym / sponsor ID
- MSS249R
- Conditions
- Behavior, Sex
- Keywords
- Unprotected anal intercourse, HIV retesting, Risk perception
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 430 participants (actual)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 Sep 2018 (actual)
- Primary completion
- 30 Sep 2019 (actual)
- Study completion
- 30 Sep 2019 (actual)
- First posted
- 6 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective The objectives of the study are to evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, increasing retesting rate and risk perception among men who have sex with men (MSM) in Hong Kong.
Participants Inclusion criteria are: 1) men of age 18 years or above using HTC services at AIDS Concern, 2) anal intercourse with at least one man in the last six months, 3) able to read and comprehend Cantonese, 4) willingness to provide contact information and to complete a simple follow up evaluation at Month 6, and 5) no intention to leave Hong Kong for one month consecutively within the next six months. Those self-reported or tested to be HIV positive will be excluded from the study.
Design A parallel-group and non-blinded randomized controlled trial (RCT) will be conducted. A total of 430 participants will be randomly allocated into the intervention group receiving EHTC (n=215) and the control group receiving SHTC (n=215). Evaluation will be performed six months afterwards.
Outcomes Primary outcomes are: 1) Prevalence of unprotected anal intercourse with any and specific types of male partners during the 6-month follow up period; 2) uptake of any type of HIV antibody testing within the 6-month follow-up period, and 3) HIV risk perception.
Detailed description
Aim To evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) that combines a component proven effective and new components involving e-health and HIV risk self-assessment versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, and increasing HIV retesting rate and risk perception among men who have sex with men (MSM) in Hong Kong.
Objectives To compare outcomes obtained from the intervention group (EHTC) and the control group (SHTC) at Month 6, including: 1) prevalence of unprotected anal intercourse with any type and specific types of male sex partners (regular and non-regular partners) in the last six months, 2) prevalence of having taken up any type of HIV antibody testing within the 6-month follow-up period, and 3) level of HIV risk perception.
Study design A parallel-group and non-blinded randomized controlled trial (RCT) will be conducted. A total of 430 participants will be randomly allocated into the intervention group receiving EHTC (n=215) and the control group receiving standard-of-care HTC (SHTC; n=215). Evaluation will be performed six month afterwards.
Recruitment procedures Users of AIDS Concern's HTC service will be approached by staff of AIDS Concern. They will brief the participants about the detail of the study and invite them to participate. Prospective participants who are interested in joining the study will be screened for their eligibility. Guarantees will be made on anonymity, right to quit at any time and that refusal will not affect their chance in using any services. Verbal instead of written informed consent will be obtained due to maintaining anonymity but the fieldworkers will sign a form pledging that the participants have been fully informed about the study.
Baseline survey and randomization Participants will complete a self-administered baseline questionnaire on site. Participants are randomized 1:1 into the intervention group and the control group. Staff of the NGO will draw one of the sealed opaque envelops to randomly allocate participants into the intervention and the control groups. Random numbers will be generated by a computer. Block randomization with block size of eight will be used.
Pre-test counselling and rapid testing All consented participants in both groups will receive the same standard-of-care pre-testing counselling, which has currently been provided by the NGO staff. It takes about five minutes to complete; it covers knowledge on HIV prevention, risk assessment, and explanation of the procedure and benefits of HTC. A rapid HIV antibody test (finger prick) will then be performed. Testing results will be known in about 15 minutes.
The control group Participants that are allocated to the control group will receive the standard-of-care HTC, which includes the previous pre-testing counselling procedures. In the post-testing counselling, participants will be explained about the negative HIV testing result (e.g. window period for screening). They will also be reminded about risk of HIV transmission, and be facilitated to set up specific goals for consistent condom use. The standard-of-care post-testing counselling lasts for about 15 minutes.
The intervention group In addition to the steps received by members of the control group, the intervention group will be exposed to four additional intervention components.
- A video clip While waiting for the HIV testing result, participants in the intervention group will watch a 10-minute video clip presenting the story of a gay man contracting sexually transmitted diseases in Hong Kong on a tablet.
- A pamphlet and post-test counselling promoting HIV retesting During the standard post-test counselling, the NGO staff will perform additional brief discussions about the importance of HIV retesting. A pamphlet promoting HIV retesting in the future six months will be prepared by this study and be distributed to participants after they have completed viewing the video.
- The e-health HIV risk calculator Through e-mail, SMS or social media means, participants will be suggested 3 and 5 months after receiving the EHTC to make a self-assessment of one's own HIV-related risk through an online personalized HIV risk self-assessment.
- Brief e-health reminder for retesting Brief SMS or social media messages will be sent to participants at Month 3 and 5.
Follow up evaluation Participants of both the intervention and control groups will be followed up six months after receiving the HTC.
Statistical analysis Intention-to-treat analysis will be conducted. Between-group (intervention versus control) baseline differences in the frequency distributions of potential confounders will be compared by using chi-square test, t-test, Mann-Whitney test or other statistics. The absolute and relative risks and number needed to treat (and their 95% confidence intervals) for the binary primary outcomes comparing the two groups at Months 6 will be derived. Adjusted comparisons between the intervention and control groups will be made for all binary outcomes, adjusting for any potential confounders showing p<.2 in the between-group baseline comparisons (if any), using modified Poisson regression with robust sandwich variance estimation. SPSS 18.0 will be used for data analysis; p<.05 (2-sided) will be taken as statistically significant. The research team is very experienced in performing data analysis.
Sample size planning Assuming the prevalence of UAI with any male partners in the last six months is 40% in the control group when measured at Month 6, a sample size of 152 per group allows us to detect a smallest between-group difference of UAI of 15% (power=0.8, alpha=0.05), taking into an expected 30% loss of follow up at Month 6. A target sample size of about 215 per group is required. The actual sample size will be 430 (215 for the intervention group and 215 for the control group).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: Interventionenhanced version of HIV testing and counseling |
| Control | Active comparator | Behavioral: Controlstandard-of-care HIV testing and counseling |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- men of age 18 years or above taking up HIV testing and counselling (HTC) at a collaborative non-governmental organization (NGO),
- anal intercourse with at least one man in the last six months
- able to read and comprehend Cantonese
- willingness to provide contact information and to complete a simple follow up evaluation at Month 6
- no intention to leave Hong Kong for one month consecutively within the next six months.
Key exclusion criteria (1 listed)
- self-reported or tested to be HIV positive
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention1. Standard-of-care HIV testing and counseling 2. Watch a video clip while waiting for the HIV testing result on a tablet. 3. Receive a pamphlet and post-test counselling promoting HIV retesting. 4. Receive the e-health HIV risk calculator through e-mail, SMS or social media means 3 and 5 months afterwards. 5. Receive brief e-health reminder for retesting at Month 3 and 5. | Behavioural | Intervention |
| ControlStandard-of-care HIV testing and counseling | Behavioural | Control |
Primary outcome
Take up any type of HIV antibody testing
Time frame: six months
Uptake of any type of HIV antibody testing within the follow-up period will be assessed at Month 6 telephone follow-up evaluation
2 secondary outcomes
Unprotected anal intercourse with any and specific types of male partners
Time frame: six months
Risk perception
Time frame: six months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2020.
- Individual participant dataSharing planned: No
Related trials for Behavior, Sex
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Recruiting
Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact Lab
Reproductive Health, Sexual Health
Not yet recruiting
HC-HMP: Healthy Choices Implementation Trial
Alcohol Drinking, HIV Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Zixin Wang, PhD principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention in people with Behavior, Sex, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Take up any type of HIV antibody testing (time frame: six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2020.